Which airway device puffs up Kids' stomachs less? new study aims to find out
NCT ID NCT07451470
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two types of laryngeal masks (LarySeal Pro and Ambu AuraGain) used in children aged 6-12 during general anesthesia. The goal is to see which device causes less air to enter the stomach, a common side effect that can lead to complications. Researchers will use ultrasound to measure stomach air volume before and after surgery. The trial involves 106 children undergoing short elective surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 106 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 to 10 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * • Age: pediatrics (6-12years ) * Patients with a Mallampati score of I - II * Elective surgeries * Short procedure expected to last for 1 hour or less . * ASA I - II Exclusion Criteria: * • Age: below 6 years and above 12 years * Patient with airway masses * Active upper respiratory tract infections, pneumonia, COPD \& exacerbated bronchial asthma. * Patient with gastroesophgeal reflux ( hiatus hernia , achalasia ) * Patient with abnormal airway anatomy * Coagulation disorders. * Patients with any cardiac conditions (IHD, RHD, decompensated heart failure and arrhythmia).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastric insufflation are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cairo Universty
RECRUITINGCairo, Cairo Governorate, 12345, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.